Under intratumoral GSH and in situ NIR sequential stimulation, the gas nanoadjuvant could achieve tumor-specific amplified H2S/CO/Mn2+ release to trigger immune responses by cGAS-STING pathway activation, which effectively assisted AIEgen-mediated PDT/PTT therapy in poorly immunogenic TNBC treatment. Here, STING1 is linked to neoplasm.